Published in Blood Weekly, December 7th, 2000
Researchers collected 132 blood specimens and heart tissue samples from 35 patients between February 1997 and May 1998. The higher the level of the substances prothrombin fragment (PF) 1.2 and p-selectin, substances circulating in the blood that are involved in clotting, the higher the rate of rejection, researchers found. Low levels of both substances predicted that the specimen would be free of rejection 88% of the time.
In addition, patients with a p-selectin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.